Showing results (151-160 of 345) with videos related to

Sort By:
Pageof 35
Clinical Pharmacokinetics|September 10, 2003
Pharmacodynamic and pharmacokinetic properties of enoxaparin : implications for clinical practiceJawed Fareed, Debra Hoppensteadt, Jeanine Walenga, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 13, 2004
Erythropoietin-induced thrombosis as a result of increased inflammation and thrombin activatable fibrinolytic inhibitorMahmut Tobu, Omer Iqbal, Daniel Fareed, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 20, 2015
Inflammation and Hemostatic Activation may Contribute to Postsurgical Thrombosis in Patients With Bladder CancerSchuharazad Abro, Melanie Clark, Guliz Barkan, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 20, 2020
Relationship Between 25-Hydroxyvitamin D, Renin, and Collagen Remodeling Biomarkers in Atrial FibrillationDimpi Patel, Aleksander Druck, Debra Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 30, 2021
Protamine Sulfate Neutralization Profile of Various Dosages of Bovine, Ovine and Porcine UFHs and Their Depolymerized Derivatives in Non-Human PrimatesAhmed Kouta, Walter Jeske, Lee Cera, et al.
Seminars in Thrombosis and Hemostasis|April 16, 2004
Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugsJeanine M Walenga, Walter P Jeske, M Margaret Prechel, et al.
The Analyst|April 25, 2019
Systematic analysis of enoxaparins from different sources with online one- and two-dimensional chromatographyYilan Ouyang, Meng Zhu, Xin Wang, et al.
Current Pharmaceutical Design|April 14, 2004
Biochemical and pharmacologic heterogeneity in low molecular weight heparins. Impact on the therapeutic profileJawed Fareed, Debra Hoppensteadt, Christopher Schultz, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 26, 2004
Molecular and pharmacologic profile of tinzaparin and a comparable low-molecular-weight bacterial sulfaminoheparosanJyothi Maddineni, Qing Ma, Debra A Hoppensteadt, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 5, 2016
Vascular endothelial growth factor: Potential predictor of treatment response in major depressionAnne Clark-Raymond, Edwin Meresh, Debra Hoppensteadt, et al.
Pageof 35